Britain's main stock indexes edged lower on Monday, dragged by losses in financial and energy sector shares, as investors ...

European shares wobbled on Monday ahead of what is likely to be an eventful week for U.S. interest rate policy, as investor ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

No wonder the S&P 500 Index is marching from one record to the next: Analysts are ratcheting up earnings estimates for the ...

Renowned investor Peter Lynch has underscored the importance of long-term investment strategies, advising against the pursuit ...

Here are three stocks favored by the Street's top pros, according to TipRanks, a platform that ranks analysts based on their ...

A declining stock price amid steadily rising payouts means Realty Income stock offers an above-average yield of 5.5% at ...

Long gone are the days of unprofitable growth for Uber. On the bottom line, the company reported a net profit of $1.4 billion ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Sticking with industry leaders is all an investor needs to do to run circles around the market indexes. The Nasdaq Composite ...

While paying off the 4.5% interest on a mortgage of $700,00 sounds questionable, it is a smart play for many reasons. The ...

Dividend investing could be draining your wealth with unexpected costs and limited growth potential. Here are some downsides, ...